Clinical trials
Multiple Myeloma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
248 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 7 |
| 2007 | 4 |
| 2008 | 8 |
| 2009 | 8 |
| 2010 | 6 |
| 2011 | 11 |
| 2012 | 9 |
| 2013 | 9 |
| 2014 | 8 |
| 2015 | 7 |
| 2016 | 16 |
| 2017 | 14 |
| 2018 | 13 |
| 2019 | 16 |
| 2020 | 9 |
| 2021 | 13 |
| 2022 | 15 |
| 2023 | 13 |
| 2024 | 19 |
| 2025 | 6 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 123 |
| Recruiting | 43 |
| Active, not recruiting | 36 |
| Terminated | 25 |
| Withdrawn | 7 |
| Unknown status | 6 |
| Not yet recruiting | 4 |
| No longer available | 3 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 23 |
| Janssen Research & Development, LLC | 21 |
| Amgen | 15 |
| GlaxoSmithKline | 15 |
| Bristol-Myers Squibb | 11 |
| Pfizer | 11 |
| University Health Network, Toronto | 11 |
| AbbVie | 10 |
| Canadian Myeloma Research Group | 6 |
| NCIC Clinical Trials Group | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 248 |
| Recurrence | 53 |
| Neoplasms, Plasma Cell | 25 |
| Neoplasms | 19 |
| Hematologic Neoplasms | 14 |
| Lymphoma | 13 |
| Lymphoma, Non-Hodgkin | 12 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 11 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 10 |
| Leukemia, Myeloid, Acute | 9 |
Trials
Showing 51 to 75 of 248. Each trial links to its page on Pharma Observatory.
148 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.